Knockdown of the Dickkopf 3 gene induces apoptosis in a lung adenocarcinoma

Il Lae Jung1, Hyo Jin Kang, Kug Chan Kim

  • 1Department of Radiation Biology, Environmental Radiation Research Group, Korea Atomic Energy Research Institute, Daejeon 305-600, Korea.

Insights

Dickkopf-3 (DKK3) acts as an anti-apoptotic molecule in non-small cell lung cancer. Silencing DKK3 expression in H460 cells promoted apoptosis by increasing reactive oxygen species.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Dickkopf (DKK) gene expression is often downregulated in tumors due to epigenetic DNA modification.
  • Four DKK members (DKK1-4) have been identified, with DKK3 playing a role in various cellular processes.
  • DKK3 is hypermethylated but still expressed in non-small cell lung cancer (NSCLC) H460 cells.

Purpose of the Study:

  • To investigate the function of Dickkopf-3 (DKK3) in non-small cell lung cancer (NSCLC) H460 cells.
  • To understand the impact of DKK3 gene silencing on NSCLC cell behavior and apoptosis.
  • To explore the molecular mechanisms underlying DKK3's role in apoptosis and reactive oxygen species regulation.

Main Methods:

  • Utilized DKK3-silencing RNA (siRNA) to interfere with DKK3 expression in H460 cells.
  • Observed cell detachment and apoptosis following DKK3 knockdown.
  • Quantified intracellular reactive oxygen species (ROS) levels.
  • Assessed the expression of apoptosis-related proteins including p53, p21, and Bax, as well as cyclin-dependent kinases D1 and E.

Main Results:

  • Knockdown of DKK3 expression led to H460 cell detachment and induced apoptosis.
  • DKK3 silencing resulted in increased intracellular reactive oxygen species (ROS) levels.
  • Expression of cyclin-dependent kinases D1 and E, p53, p21, and Bax was elevated post-DKK3 knockdown.
  • These molecular changes indicate entry into the apoptotic pathway.

Conclusions:

  • DKK3 functions as an anti-apoptotic molecule in non-small cell lung cancer.
  • DKK3 exerts its anti-apoptotic effect by reducing intracellular reactive oxygen species (ROS).
  • Targeting DKK3 may represent a potential therapeutic strategy for NSCLC.